Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ: PACB )

1.690 +0.040 (+2.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,426,716
Open 1.690
Bid (Size) 1.690 (1)
Ask (Size) 1.700 (50)
Prev. Close 1.650
Today's Range 1.610 - 1.715
52wk Range 1.160 - 7.500
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Analysts Are Saying About Pacific Biosciences Stock
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025. 
Via The Motley Fool

Performance

YTD
-6.11%
-6.11%
1 Month
-12.44%
-12.44%
3 Month
-4.52%
-4.52%
6 Month
-20.84%
-20.84%
1 Year
-76.20%
-76.20%

More News

Read More
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
What 5 Analyst Ratings Have To Say About Pacific Biosciences
Via Benzinga
Analyst Scoreboard: 5 Ratings For Pacific Biosciences
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Peering Into Pacific Biosciences's Recent Short Interest
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
Via Benzinga
A Biotech Breakout Will Be Led By Small Caps
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday
Via Benzinga
Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.